These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26866492)

  • 1. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
    Hosp C; Naumann MK; Hamm H
    Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment of secretory disorders.
    Naumann M; Jost W
    Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
    Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
    Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatments for excessive armpit sweating.
    Drug Ther Bull; 2005 Oct; 43(10):77-80. PubMed ID: 16240957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sialorrhea, hyperhidrosis and botulinum toxin].
    Monnier G; Tatu L; Parratte B; Cosson A; Michel F; Metton G
    Ann Readapt Med Phys; 2003 Jul; 46(6):338-45. PubMed ID: 12928141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for hyperhidrosis of areas other than the axillae and palms/soles.
    Glaser DA; Galperin TA
    Dermatol Clin; 2014 Oct; 32(4):517-25. PubMed ID: 25152345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhidrosis: Management Options.
    McConaghy JR; Fosselman D
    Am Fam Physician; 2018 Jun; 97(11):729-734. PubMed ID: 30215934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
    Glaser DA
    Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin for treatment of glandular hypersecretory disorders.
    Laing TA; Laing ME; O'Sullivan ST
    J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1024-8. PubMed ID: 18619934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of focal hyperhidrosis.
    Murray CA; Cohen JL; Solish N
    J Cutan Med Surg; 2007; 11(2):67-77. PubMed ID: 17374317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for hyperhidrosis: a review.
    Grunfeld A; Murray CA; Solish N
    Am J Clin Dermatol; 2009; 10(2):87-102. PubMed ID: 19222249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.